NEW YORK – CVS Health Corp. said it received a subpoena on behalf of the U.S. Drug Enforcement Administration, asking the company for information about its handling of opioids and other controlled substances.
Federal authorities are investigating potential violations of two federal laws: the Controlled Substances Act, which regulates addictive drugs, and the False Claims Act, which prohibits companies from improperly benefiting from government health programs. The subpoena was sent in January by the Justice Department of behalf the the DEA, CVS said in a regulatory filing Tuesday.
Rhode Island FC To Offer Local Businesses Top-Notch Networking Opportunities in 2025
The perfect atmosphere for entertaining clients or hosting employees, The Stadium at Tidewater Landing will…
Learn More
Federal authorities are looking into “practices with respect to opioids and other controlled substances at CVS Pharmacy locations,“ according to the filing. It wasn’t clear whether the matter was limited to behavior at certain CVS locations or if it was a broader corporate issue.
CVS didn’t immediately respond to a request for comment. The company said in the filling that it’s cooperating with the government on the inquiry. The Woonsocket-based pharmacy, drug benefits and insurance company said in the filing that it’s routinely audited by the DEA.
Drew Armstrong is a reporter for Bloomberg News.
